Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay

BACKGROUND: The PAM50 assay is used routinely in clinical practice to determine breast cancer prognosis and management; however, research assessing how technical variation and intratumoral heterogeneity contribute to misclassification and reproducibility of these tests is limited. METHODS: We evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurson, Amber N., Hamilton, Alina M., Olsson, Linnea T., Kirk, Erin L., Sherman, Mark E., Calhoun, Benjamin C., Geradts, Joseph, Troester, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147733/
https://www.ncbi.nlm.nih.gov/pubmed/36892725
http://dx.doi.org/10.1007/s10549-023-06888-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147733/
https://www.ncbi.nlm.nih.gov/pubmed/36892725
http://dx.doi.org/10.1007/s10549-023-06888-1

Ejemplares similares